Former Executive Vice President and President, Research and Development · Sana Biotechnology, Inc. (SANA)

Douglas Williams

A named executive officer of Sana Biotechnology in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,754,070

Salary $190,820Stock awards $436,710

FY2023: $3,044,751

3rd of 4 named executive officers at Sana Biotechnology by FY2024 total.

4 named officers on file for Sana Biotechnology, FY2024

Douglas Williams’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Sana Biotechnology’s whole pay program stands against its peers

  • Sana Biotechnology’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SANA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Douglas Williams’s full pay file as a PDF — free

More than this page: up to 10 years of Douglas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Douglas Williams compensation by year

Sana Biotechnology Summary Compensation Table · all 2 fiscal years held
In US dollars, as Sana Biotechnology reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$412,692$190,820
Bonus$0$0
Stock awards$30,800$436,710
Option awards$2,376,859$1,965,206
Non-equity incentive$220,400$0
Pension and deferred compensation$0$0
All other$4,000$161,333
Total$3,044,751$2,754,070

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sana Biotechnology, Inc. DEF 14A filed April 25, 2025, accession 0001193125-25-094656, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Sana Biotechnology, Inc. filed document, accession 0001193125-25-094656. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

$3.0M
$2.8M
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU10,000$40,800—
Option1,100,000—$3.28

Per the Outstanding Equity Awards at Fiscal Year-End table in Sana Biotechnology, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Sana Biotechnology’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Steven HarrPresident, Chief Executive Officer, and Director$8,788,580
Nathan HardyFormer Executive Vice President, Chief Financial Officer$3,050,230
Douglas Williams · this pageFormer Executive Vice President and President, Research and Development$2,754,070
Bernard CassidyExecutive Vice President, General Counsel, and Corporate Secretary$2,345,597

The full Sana Biotechnology compensation record

free company brief

This page is one person within Sana Biotechnology's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sana Biotechnology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Douglas Williams's compensation dossier · One-time report. No refunds.